The recent push by Oura Health to expand its lobbying presence in Washington has reignited a broader debate over how wearable health technologies should be regulated — and how they could be deployed in public systems, including military and veteran healthcare.
While much of the attention has centered on the Oura Ring, policymakers are increasingly evaluating an entire ecosystem of biometric wearables. Devices such as the Apple Watch, WHOOP Strap, and continuous glucose monitors (CGMs) are capable of tracking heart rate variability, sleep cycles, oxygen saturation, temperature trends, glucose levels, and other physiological markers in near real time.
In civilian healthcare, these tools are often marketed as wellness products. In military and veteran contexts, however, the implications are far more strategic.
The U.S. military has long explored performance optimization technologies to monitor troop readiness, fatigue, and recovery. Wearables offer the promise of detecting early warning signs of overtraining, dehydration, stress injuries, or sleep deprivation before they escalate into operational risk. In veteran healthcare systems, including the U.S. Department of Veterans Affairs, wearable data could supplement clinical care for chronic conditions such as cardiovascular disease, diabetes, PTSD, and traumatic brain injury.
The policy question is no longer whether wearable devices will be used in these settings — but how.
Advocates argue that wearable adoption could enhance preventive care models within military treatment facilities and VA hospitals, shifting care from episodic visits to continuous monitoring. Remote biometric tracking could reduce hospital readmissions, flag irregular heart rhythms, or provide objective sleep and stress metrics to support behavioral health interventions.
Yet critics caution that introducing consumer-grade devices into federally funded health systems carries legal, ethical, and cybersecurity considerations.
Wearables generate continuous streams of highly sensitive health data. In civilian settings, that data is often governed by company privacy policies rather than traditional healthcare regulations. If federal agencies were to subsidize or formally integrate these tools into military or veteran care, questions arise about who owns the data, where it is stored, and how it may be accessed.
Joanne Frederick is the founder of Government Market Strategies (GMS), a leading force in government healthcare consulting. Her expertise lies in strategic innovation, organizational design, and seamless deployment. She founded GMS to be a platform for designing forward-thinking strategies, building resilient organizations, and delivering results where others see only complexity.
“The Oura Ring is a powerful feedback tool that gives individuals insight into their own ‘operating system’ each day,” Frederick said. “As a consistent subscriber since 2020, I’ve seen how access to real-time health data can increase awareness and personal accountability. From a policy standpoint, empowering people to better understand their own health is a positive development. Where things become more complicated is when government sponsorship of a device potentially intersects with access to personal health data. Any public-sector partnership involving wearable technology must draw a bright line around individual data ownership and privacy. The goal should be to create cultures and structures that strengthen personal agency — not systems that centralize sensitive health information.”
Military healthcare environments introduce additional layers of sensitivity. Biometric data collected from active-duty service members could theoretically reveal readiness levels or vulnerabilities. Without rigorous safeguards, such data might present national security risks if compromised. For veterans, many of whom already navigate complex disability and benefits systems, clarity around consent and data use would be essential.
Regulators are also weighing how wearables should be classified. Some companies advocate for a distinct regulatory category for low-risk health trackers, separate from FDA-cleared medical devices. Others argue that once wearable data informs clinical decisions within systems like the Department of Defense or the VA, higher regulatory scrutiny becomes appropriate.
The debate unfolding in Washington is therefore larger than any single company. It represents a crossroads for digital health policy. Wearables may offer scalable tools to improve readiness, chronic disease management, and preventive care across military and veteran populations. But their integration into federal healthcare systems demands strict guardrails around cybersecurity, interoperability standards, and individual data rights.
As policymakers evaluate proposals and industry lobbying efforts, the future of wearable technology in military and veteran healthcare will likely hinge on a central principle: innovation must advance alongside privacy protections — not ahead of them.
